腔静脉减影二维相位对比MRI测量全肝血流与肝动脉血流:在慢性肝病患者中的原理验证、与门静脉高压严重程度的相关性及验证
这项原理验证研究前瞻性纳入12例组织学确诊的肝硬化患者,采用腔静脉减影二维相位对比MRI测量全肝血流量和肝动脉血流,并与直接流入法MRI、肝静脉压力梯度及吲哚菁绿清除率对比。腔静脉减影法全肝血流量与直接流入法MRI测量结果一致,肝动脉分数与肝静脉压力梯度呈正相关(r=0.780,P=0.014),与吲哚菁绿清除率全肝血流量一致性中等。作者认为有必要开展更大规模研究探讨全肝血流量和肝动脉血流测量在肝病患者中的临床作用。
要点
- 腔静脉减影法肝动脉分数与肝静脉压力梯度正相关(r=0.780,P=0.014)。
- 腔静脉减影法全肝血流量与直接流入法MRI平均差异6.3±4.2 mL/min/100 g。
- 腔静脉减影法与吲哚菁绿清除率全肝血流量平均差异-32.6±16.6 mL/min/100 g。
核心结论
- 在肝硬化患者中,腔静脉减影相位对比MRI测量结果与直接流入法MRI一致,肝动脉分数与门静脉高压严重程度相关,与有创全肝血流量测量一致性中等。
研究设计与样本
- 前瞻性原理验证研究,纳入12例组织学确诊的肝硬化患者(平均50.8±3.1岁,10例男性),行门静脉、肝下下腔静脉和肝上下腔静脉二维相位对比MRI,并在MRI后7天内测量肝静脉压力梯度和吲哚菁绿清除率全肝血流量。
诊断标准与关键数值
- 腔静脉减影全肝血流量与直接流入法MRI平均差异6.3±4.2 mL/min/100 g,Bland-Altman 95%一致性界限±28.7 mL/min/100 g。
- 肝静脉压力梯度与腔静脉减影肝动脉分数正相关(r=0.780,P=0.014)。
- 肝静脉压力梯度与肝动脉血流(r=0.625,P=0.053)、门静脉血流(r=0.244,P=0.469)、腔静脉减影全肝血流量(r=0.473,P=0.141)均无显著相关。
- 腔静脉减影法与吲哚菁绿清除率全肝血流量平均差异-32.6±16.6 mL/min/100 g,Bland-Altman 95%一致性界限±79.7 mL/min/100 g。
- 腔静脉减影法与吲哚菁绿清除率全肝血流量的变异系数无显著差异(65.7% vs 48.1%,P=0.28)。
临床应用与阅片要点
- 作者认为有必要开展更大规模研究探讨全肝血流量和肝动脉血流测量在肝病患者中的临床作用。
局限性
- 作者指出本研究为原理验证研究,样本量有限。
- 腔静脉减影法与吲哚菁绿清除率全肝血流量的一致性仅为中等(平均差异-32.6±16.6 mL/min/100 g,Bland-Altman 95%一致性界限±79.7 mL/min/100 g)。
- 作者认为有必要开展更大规模研究探讨全肝血流量和肝动脉血流测量在肝病患者中的临床作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Caval subtraction phase-contrast magnetic resonance imaging (PCMRI) noninvasive measurements of total liver blood flow (TLBF) and hepatic arterial (HA) flow have been validated in animal models and translated into normal volunteers, but not patients. This study aims to demonstrate its use in patients with liver cirrhosis, evaluate measurement consistency, correlate measurements with portal hypertension severity, and invasively validate TLBF measurements.
MATERIALS AND METHODS: Local research ethics committee approval was obtained. Twelve patients (mean, 50.8 ± 3.1 years; 10 men) with histologically confirmed cirrhosis were recruited prospectively, undergoing 2-dimensional PCMRI of the portal vein (PV) and the infrahepatic and suprahepatic inferior vena cava. Total liver blood flow and HA flow were estimated by subtracting infrahepatic from suprahepatic inferior vena cava flow and PV flow from estimated TLBF, respectively. Invasive hepatic venous pressure gradient (HVPG) and indocyanine green (ICG) clearance TLBF were measured within 7 days of PCMRI. Bland-Altman (BA) analysis of agreement, coefficients of variation, and Pearson correlation coefficients were calculated for comparisons with direct inflow PCMRI, HVPG, and ICG clearance.
RESULTS: The mean difference between caval subtraction TLBF and direct inflow PCMRI was 6.3 ± 4.2 mL/min/100 g (BA 95% limits of agreement, ±28.7 mL/min/100 g). Significant positive correlations were observed between HVPG and caval subtraction HA fraction (r = 0.780, P = 0.014), but not for HA flow (r = 0.625, P = 0.053), PV flow (r = 0.244, P = 0.469), or caval subtraction TLBF (r = 0.473, P = 0.141). Caval subtraction and ICG TLBF agreement was modest (mean difference, -32.6 ± 16.6 mL/min/100 g; BA 95% limits of agreement, ±79.7 mL/min/100 g), but coefficients of variation were not different (65.7% vs 48.1%, P = 0.28).
CONCLUSIONS: In this proof-of-principle study, caval subtraction PCMRI measurements are consistent with direct inflow PCMRI, correlate with portal hypertension severity, and demonstrate modest agreement with invasive TLBF measurements. Larger studies investigating the clinical role of TLBF and HA flow measurement in patients with liver disease are justified.
引用
- Chouhan MD, Mookerjee RP, Bainbridge A, et al. Caval Subtraction 2D Phase-Contrast MRI to Measure Total Liver and Hepatic Arterial Blood Flow: Proof-of-Principle, Correlation With Portal Hypertension Severity and Validation in Patients With Chronic Liver Disease. Invest Radiol. 2017. PMID: 27805917. doi:10.1097/RLI.0000000000000328
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。